In EDS ansehen

Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials: analysis of two phase 2 trials

Gespeichert in:

Bibliographische Detailangaben
Titel:	Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials: analysis of two phase 2 trials
Autoren:	Bolhuis, M S, Akkerman, O W, Sturkenboom, M G G, van Boven, J F M, Alffenaar, J-W C, Stevens, J
Quelle:	The International Journal of Tuberculosis and Lung Disease. 27:335-337
Verlagsinformationen:	International Union Against Tuberculosis and Lung Disease, 2023.
Publikationsjahr:	2023
Schlagwörter:	Diabetes Complications, Diarylquinolines/therapeutic use, Antitubercular Agents/therapeutic use, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Tuberculosis, Humans, Multidrug-Resistant/complications, Diabetes Complications/complications, Diarylquinolines
Publikationsart:	Article
Sprache:	English
ISSN:	1027-3719
DOI:	10.5588/ijtld.22.0581
Zugangs-URL:	https://pubmed.ncbi.nlm.nih.gov/37035978
Dokumentencode:	edsair.doi.dedup.....06cbaf522f4d0f2e5fb1f4f16f5a2f36
Datenbank:	OpenAIRE

Beschreibung
ISSN:	10273719
DOI:	10.5588/ijtld.22.0581